Lactobacillus rhamnosus HN001 and Reduced Abdominal Pain

• Effects of Bifidobacterium longum BB536 and Lactobacillus rhamnosus HN001 in IBS patients

  • 2020-02-12
  • Clinical Trial
  • European Journal of Clinical Investigation 50(3)
  • • L. Bonfrate
    • D. D. Di Palo
    • G. Celano
    • A. Albert
    • Paola Vitellio
    • M. De Angelis
    • M. Gobbetti
    • P. Portincasa

  • PubMed: 31960952
  • DOI: 10.1111/eci.13201

  7 Insights on

  • Reduced Abdominal Pain

  • High evidence
  • Rigorous Journal

  Percentage decrease from baseline of abdominal pain (-48.8% vs -3.5%) was significantly (P < .0001) greater with LBB than placebo, respectively.

  Effect

  Beneficial

  Effect size

  Large

  Significant

  Yes